Charles Explorer logo
🇬🇧

Avanafil - a novel phosphodiesterase inhibitor for treating erestile dyscunction in clinical practice. How is it different from the established molecules?

Publication at Third Faculty of Medicine |
2015

Abstract

Phosphodiesterase-5 inhibitors are drugs of choice for erectile dysfunction treatment. Now, there is new one molecule on the marketavanafil.

What is the difference between avanafil and other PDE-5 inhibitors?